Genmab A GMAB
NASDAQ GMAB
$43.79 +3.79 (+9.48%)
At close: Oct 23, 2026 · 4:00 PM EDT

Genmab A (GMAB) Price to Earnings (2025 - 2026)

Updated

Genmab A's (GMAB) Price to Earnings came in at 0.97 for the quarter ended Jun 30, 2026, down 3.7% from the prior quarter.

Analysis

Genmab A (GMAB) Price to Earnings (2025 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Genmab A's Price to Earnings stood at 2.05, up 8.6% from the prior year.

  • In prior years, Genmab A's Price to Earnings was 1.89 in the year ended Dec 31, 2024 (-63.0%), 5.12 in the year ended Dec 31, 2023 (-6.8%), 5.49 in the year ended Dec 31, 2022 (-27.5%) and 7.57 in the year ended Dec 31, 2021 (+12.0%).
  • Quarterly Price to Earnings has run from a low of 0.91 in the quarter ended Sep 30, 2025 to a high of 4.04 in the quarter ended Jun 30, 2023 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Genmab A 2.87 Bn -2.51 Bn 1.07 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.99
Mar 31, 2026 2.03
Sep 30, 2025 1.60
Jun 30, 2025 1.32
Mar 31, 2025 1.45
API Access

Genmab A Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=GMAB&period=max&api_key=YOUR_API_KEY